Duloxetine in treatment of anxiety symptoms associated with depression.
about
Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients.Efficacy and tolerability of duloxetine treatment in elderly patients with major depressive disorder and concurrent anxiety symptoms.Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders.Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physiciansSomatic symptoms in late-life anxiety: treatment issues.Duloxetine: a new selective and dual-acting antidepressant.Anxiety but not social stressors predict 12-month depression and pain severity.Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart review.The role of duloxetine in the treatment of anxiety disorders.Duloxetine in the treatment of major depressive disorder.Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentaryUse of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders.
P2860
Q33987958-8DEBD1F6-8414-4B44-92C3-7FF7ADFA2B46Q34064324-2A857CF5-4C2C-4B98-869F-03A25937FBD7Q34662418-D9F31551-2917-41D6-B16E-3823724FF3A4Q35036911-9C5C771E-E1BB-41B0-8256-77F64FCE20D7Q35088837-81D2FAE4-7EB3-47D5-A29B-5F56A5B4322FQ35851104-47D459CD-214E-4E3A-8C51-F777558B3637Q36136420-CF7F5AAD-D585-4472-914A-B349ECEB29A1Q36407366-EED08A43-C7E4-46B4-AD99-B0BC4C1352F8Q36487554-1235F11D-3646-4692-A064-4BF7B1FEB530Q36947157-38BE3CA0-2A70-47DA-A59F-9C33766F4415Q37062590-F6B329D8-C908-4703-85D5-7752842A546CQ37125752-89DB3355-99ED-46EB-948E-AEBACEAF824AQ37289129-FA790D66-D9FF-441F-8A3B-1A87D9D76596Q37449200-FF24A938-142A-4F4C-AC86-501E4F8598D5Q37733559-6B96C42E-BF82-4910-9BD1-FF55E65EDC2CQ42619331-D341D418-3873-4809-9747-E888CFC956D9Q48063859-254333DB-5B63-496C-895C-FDA192B128F9
P2860
Duloxetine in treatment of anxiety symptoms associated with depression.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Duloxetine in treatment of anxiety symptoms associated with depression.
@en
Duloxetine in treatment of anxiety symptoms associated with depression.
@nl
type
label
Duloxetine in treatment of anxiety symptoms associated with depression.
@en
Duloxetine in treatment of anxiety symptoms associated with depression.
@nl
prefLabel
Duloxetine in treatment of anxiety symptoms associated with depression.
@en
Duloxetine in treatment of anxiety symptoms associated with depression.
@nl
P2093
P356
P1476
Duloxetine in treatment of anxiety symptoms associated with depression.
@en
P2093
Craig Mallinckrodt
David J Goldstein
David L Dunner
Michael J Detke
P356
10.1002/DA.10122
P577
2003-01-01T00:00:00Z